Skip to main content
Log in

Renal dysfunction induced by cadmium: biomarkers of critical effects

  • Published:
Biometals Aims and scope Submit manuscript


Cadmium (Cd) is cumulative poison which can damage the kidneys after prolonged exposure in the industry or the environment. Renal damage induced by Cd affects primarily the cellular and functional integrity of the proximal tubules, the main site of the renal accumulation of the metal. This results in a variety of urinary abnormalities including an increased excretion of calcium, amino acids, enzymes and proteins. These effects have been documented by a large number of studies conducted during more than two decades in experimental animals and in populations environmentally or occupationally exposed to Cd. There is now a general agreement to say that the most sensitive and specific indicator of Cd-induced renal dysfunction is a decreased tubular reabsorption of low molecular weight proteins, leading to the so-called tubular proteinuria. β2-microblobulin, retinol-binding protein and α1-microglobulin are the microproteins the most commonly used for screening renal damage in populations at risk. Tubular dysfunction develops in a dose-dependent manner according to the internal dose of Cd as assessed on the basis of Cd levels in kidney, urine or in blood. Depending on the sensitivity of the renal biomarker and the susceptibility of the exposed populations, the thresholds of urinary Cd vary from 2 to 10 μg/g creatinine. The thresholds associated with the development of the microproteinuria, the critical effect predictive of a decline of the renal function, is estimated around 10 μg/g creatinine for both occupationally and environmentally exposed populations. Much lower thresholds have been reported in some European studies conducted on the general population. These low thresholds, however, have been derived from associations whose causality remains uncertain and for urinary protein increases that might be reversible. Cd-induced microproteinuria is usually considered as irreversible except at the incipient stage of the intoxication where a partial or complete reversibility has been found in some studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  • Bernard AM, Moreau D, Lauwerys R. 1982 Comparison of retinol-binding protein and beta2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 126, 1–7.

    Google Scholar 

  • Bernard A, Ouled Amor A, Lauwerys R. 1987 The effects of low doses of cadmium-metallothionein on the renal uptake of b2-microglobulin in rats. Toxicol Appl Pharmacol 87, 440–445.

    Google Scholar 

  • Bernard A, Roels H, Buchet JP, Cardenas A, Lauwerys R. 1992 Cadmium and health: the Belgian experience. IARC-Sci-Publ. 118, 15–33.

  • Bernard A, Thielemans N, Lauwerys R. 1994 Urinary protein 1 or Clara cell protein: a new sensitive markers of proximal tubular dysfunction. Kidney International 46, S34–S37.

    Google Scholar 

  • Bernard A. Biomarkers in surveillance of workers exposed to cadmium. 1996 Int J Occup Environ Health3, 533–536.

    Google Scholar 

  • Bernard A. 1996b. The determination of â 2-microglobulin, retinol-binding protein and alpha1-microglobulin in urine. In: Biolo-gicalmonitoring of chemical exposure in the workplace.WH0, Geneva, pp. 74–90.

  • Buchet JP, Lauwerys R, Roels H, Bernard A, Bruaux P, Claeys F, Ducoffre G, de Plaen P, Staessen J, Amery A. 1990 Renal effects of cadmium body burden of the general population. Lancet 336, 699–702.

    Google Scholar 

  • Hotz P, Buchet JP, Bernard A, Lison D, Lauwerys R. 1999 Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. Lancet 30, 1508–1513.

    Google Scholar 

  • Jarup L, Hellstrom L, Alfven T, Carlsson MD, Grubb A, Persson B, Pettersson C, Spang G, Schutz A, Elinder CG. 2000 Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 57, 668–672.

    Google Scholar 

  • Jin T, Nordberg M, Frech W, Dumont X, Bernard A, Ye T, Kong Q, Wang Z, Li P, Lundström N, Li Y, Nordberg. 2002 Cad-mium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). Biometals 15, 397–410.

    Google Scholar 

  • Ikeda M, Ezaki T, Tsukahara T, Moriguchi J, Furuki K, Fukui Y, Ukai H, Okamoto S, Sakurai H. 2003 Threshold levels of urinary cadmium in relation to increases in urinary beta2-microglobulin among general Japanese populations. Toxicol Lett 137, 135–141.

    Google Scholar 

  • Nordberg G, Jin T, Bernard A, Fierens S, Buchet JP, Ye T, Kong G, Wang H. 2002, Low bone density and renal dysfunction follow-ing environmental cadmium exposure. Ambio31, 478–481.

    Google Scholar 

  • Wu X, Jin T, Wang Z, Ye T, Kong Q, Nordberg G. 2001 Urinary cal-cium as a biomarker of renal dysfunction in a general population exposed to cadmium. J Occup Environ Med 43, 898–904.

    Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernard, A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 17, 519–523 (2004).

Download citation

  • Issue Date:

  • DOI: